GKOS
GLAUKOS Corp
NYSE · Healthcare · Medical - Devices · US
$163.81
+1.48%Forward multiples
Based on analyst estimates
- P/E forward
- 1068.32x
- P/E 2026E
- —
- P/E 2027E
- 316.93x
- P/E 2028E
- 97.47x
- P/S forward
- 12.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.16x
- Price / sales
- 15.77x
- Price / cash flow
- -10170.69x
Enterprise value
- Enterprise value
- $9.5B
- EV / sales
- 15.47x
- EV / EBITDA
- -66.63x
- EV / EBIT
- -117.76x
- Market cap
- $9.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026